CAS number: 309-00-2
NIOSH REL: 0.25 mg/m3 TWA [skin]; NIOSH considers aldrin to be a potential occupational carcinogen as defined by the OSHA carcinogen policy [29 CFR 1990].
Current OSHA PEL: 0.25 mg/m3 TWA [skin]
1989 OSHA PEL: Same as current PEL
1993-1994 ACGIH TLV: 0.25 mg/m3 TWA [skin]
Description of substance: Colorless to dark-brown crystalline solid with a mild chemical odor.
LEL: Noncombustible Solid
Original (SCP) IDLH: 100 mg/m3
Basis for original (SCP) IDLH: No useful data on acute inhalation toxicity are available on which to base the IDLH for aldrin. The chosen IDLH, therefore, has been estimated from the statement by Baskin [1975] that severe symptoms follow swallowing or skin contamination with 15 to 50 mg/kg (average adult). According to Deichmann [1973], aldrin vapor gave no effect in man at 18 mg/m3 during exposure for 1 day.
Short-term exposure guidelines: None developed
| Adjusted | ||||||
|---|---|---|---|---|---|---|
| LC50 | LCLo | 0.5-hr | Derived | |||
| Species | Reference | (ppm) | (ppm) | Time | LC (CF) | Value |
| Rat | Izmerov et al. 1982 | ----- | 5.8 mg/m3 | 4 hr | 12 mg/m3 (2.0) | 1.2 mg/m3 |
| LL50 | LCLo | Derived | ||||
|---|---|---|---|---|---|---|
| Species | Reference | Route | (mg/kg) | (mg/kg) | Adjusted LD | Value |
| Rabbit | AAPCO 1966 | oral | 50 | ----- | 350 mg/m3 | 35 mg/m3 |
| G. pig | AAPCO 1966 | oral | 33 | ----- | 231 mg/m3 | 23 mg/m3 |
| Rat | Kenaga and Morgan 1978 | oral | 39 | ----- | 273 mg/m3 | 27 mg/m3 |
| Mouse | Kenaga and Morgan 1978 | oral | 44 | ----- | 308 mg/m3 | 31 mg/m3 |
Human data: No effects were noted after exposure to 18 mg/m3 for 1 day [Deichmann 1973]. Ingestion of 25.6 mg/kg caused convulsions within 20 minutes [Ottolenghi et al. 1974]. [Note: An oral dose of 25.6 mg/kg is equivalent to a 70-kg worker being exposed to about 1,200 mg/m3 for 30 minutes, assuming a breathing rate of 50 liters per minute and 100% absorption.]
Revised IDLH: 25 mg/m3
Basis for revised IDLH: The revised IDLH for aldrin is 25 mg/m3 based on acute toxicity data in humans [Deichmann 1973; Ottolenghi et al. 1974]. [Note: NIOSH recommends as part of its carcinogen policy that the "most protective" respirators be worn for aldrin at concentrations above 0.25 mg/m3.]
Go back to the Documentation for Immediately Dangerous To Life or Health Concentrations (IDLHs)
This page was last updated 8/16/96:
Go back to the NIOSH home page
or to the CDC home page.
![]()